Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
3-(2,4-Dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at
α
7-nicotinic acetylcholine receptors and is now in early clinical development for treatment of deficits in neurocognition and sensory gating in schizophrenia. During its initial phase 2 test, functional magnetic resonance imaging (fMRI) studies were conducted to determi...
Alternative Titles
Full title
Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2834253
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2834253
Other Identifiers
ISSN
0893-133X
E-ISSN
1740-634X
DOI
10.1038/npp.2009.196
